Sigrun Pedersen

4WEB Medical Announces Commercial Launch of its Cervical Spine Integrated Plating Solution

2 min read

4WEB Medical Announces Commercial Launch of its Cervical Spine Integrated Plating Solution

4WEB Medical, an orthopedic implant company focused on developing innovative implants that utilize its proprietary Truss Implant...

Read More

AbbVie Employees in Mumbai Volunteer During 9th Annual “Week of Possibilities” to Support Young Adults with Cerebral Palsy

2 min read

AbbVie Employees in Mumbai Volunteer During 9th Annual “Week of Possibilities” to Support Young Adults with Cerebral Palsy

AbbVie, a global biopharmaceutical company focused on creating innovative medicines and solutions that address complex health issues...

Read More

Manasthali gives a new lease of life to a young man affected by Schizophrenia

2 min read

Manasthali gives a new lease of life to a young man affected by Schizophrenia

Manasthali, a renowned mental health organization dedicated to offering innovative and compassionate treatment, has revitalised the life...

Read More

A pioneering two-day workshop in Bangalore to understand how climate change and caste and gender discrimination can make infections harder to treat

2 min read

A pioneering two-day workshop in Bangalore to understand how climate change and caste and gender discrimination can make infections harder to treat

The One Health Trust, funded by the World Health Organization and the British Academy, hosted a two-day...

Read More

Sana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHP

3 min read

Sana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHP

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells,...

Read More

Human Acellular Vessel™ (HAV™) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma

3 min read

Human Acellular Vessel™ (HAV™) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma

Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial...

Read More

Securing the Future: A Comprehensive Analysis of Emerging Cyber Threats Targeting Healthcare Systems

3 min read

Securing the Future: A Comprehensive Analysis of Emerging Cyber Threats Targeting Healthcare Systems

The author of this article is Mr Raj Sivaraju, President, APAC, Arete In a country’s socioeconomic landscape, the...

Read More

Mission Therapeutics announces US FDA approval to initiate Phase II clinical trial of its lead asset MTX652 in Acute Kidney Injury

2 min read

Mission Therapeutics announces US FDA approval to initiate Phase II clinical trial of its lead asset MTX652 in Acute Kidney Injury

Mission Therapeutics (“Mission” or the “Company”), a clinical-stage biotech developing first-in-class therapeutics targeting mitophagy, today announces that...

Read More

Sightsavers India’s Eight–State Inclusive Education Programme Bags the Zero Award 2024

2 min read

Sightsavers India’s Eight–State Inclusive Education Programme Bags the Zero Award 2024

Sightsavers India won the Zero Project Award 2024 for its Eight–State Inclusive Education Programme’s concerted effort for...

Read More

Gilgamesh Pharmaceuticals Successfully Completes Phase 1 SAD Clinical Trial of GM-2505

2 min read

Gilgamesh Pharmaceuticals Successfully Completes Phase 1 SAD Clinical Trial of GM-2505

Gilgamesh Pharmaceuticals, a clinical-stage neuroscience biotech developing best-in-class medicines to redefine mental healthcare, announces the successful completion...

Read More